Cargando…
Phosphorylation of Fas‐associated Death Domain Contributes to Enhancement of Etoposide‐induced Apoptosis in Prostate Cancer Cells
Fas‐associated death domain (FADD) plays an important role as an adapter molecule in Fas (CD95/APO‐l)‐mediated apoptosis and contributes to anticancer drug‐induced cytotoxicity. We treated three human prostate cancer cell lines with etoposide, a toposiomerase II inhibitor with activity against vario...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926882/ https://www.ncbi.nlm.nih.gov/pubmed/12417047 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01219.x |
_version_ | 1783318989682769920 |
---|---|
author | Shimada, Keiji Nakamura, Mitsutoshi Ishida, Eiwa Kishi, Munehiro Yonehara, Shin Konishi, Noboru |
author_facet | Shimada, Keiji Nakamura, Mitsutoshi Ishida, Eiwa Kishi, Munehiro Yonehara, Shin Konishi, Noboru |
author_sort | Shimada, Keiji |
collection | PubMed |
description | Fas‐associated death domain (FADD) plays an important role as an adapter molecule in Fas (CD95/APO‐l)‐mediated apoptosis and contributes to anticancer drug‐induced cytotoxicity. We treated three human prostate cancer cell lines with etoposide, a toposiomerase II inhibitor with activity against various tumors including prostate cancer. We found that the overexpression of FADD sensitizes etoposide‐induced apoptosis through a rapid activation of c‐Jun NH(2)‐terminal kinase (JNK) and, subsequently, of caspase 3. In addition, phosphorylation of FADD at serine 194 coincided with this sensitization. Treatment with the caspase 3 inhibitor, N‐acetyl‐Asp‐Glu‐Val‐Asp‐aldehyde (DEVD‐CHO), or overexpression of either mitogen‐activated protein kinase kinase (MKK) 7 or Bcl‐xL canceled FADD‐mediated sensitization to etoposide‐induced apoptosis. Moreover, treatment with the caspase 8 inhibitor, benzyloxy‐carbonyl‐Val‐Ala‐Asp‐fluoromethylketone (z‐IETD‐fmk), or overexpression of viral FLICE/caspase‐8‐inhibitory protein (FLIP) from equine herpesvirus type 2 E8 also had an inhibitory effect, supporting a major involvement of a caspase 8‐dependent mitochondrial pathway. Interestingly, FADD was phosphorylated, and etoposide‐induced JNK/caspase activation and apoptosis were enhanced in the cells arrested at G2/M transition, but not in those overexpressing mutant FADD, in which 194 serine was replaced by alanine. Our results demonstrate that phosphorylated FADD‐dependent activation of the JNK/caspase pathway plays a pivotal role in sensitization to etoposide‐induced apoptosis in prostate cancer cells. |
format | Online Article Text |
id | pubmed-5926882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59268822018-05-11 Phosphorylation of Fas‐associated Death Domain Contributes to Enhancement of Etoposide‐induced Apoptosis in Prostate Cancer Cells Shimada, Keiji Nakamura, Mitsutoshi Ishida, Eiwa Kishi, Munehiro Yonehara, Shin Konishi, Noboru Jpn J Cancer Res Article Fas‐associated death domain (FADD) plays an important role as an adapter molecule in Fas (CD95/APO‐l)‐mediated apoptosis and contributes to anticancer drug‐induced cytotoxicity. We treated three human prostate cancer cell lines with etoposide, a toposiomerase II inhibitor with activity against various tumors including prostate cancer. We found that the overexpression of FADD sensitizes etoposide‐induced apoptosis through a rapid activation of c‐Jun NH(2)‐terminal kinase (JNK) and, subsequently, of caspase 3. In addition, phosphorylation of FADD at serine 194 coincided with this sensitization. Treatment with the caspase 3 inhibitor, N‐acetyl‐Asp‐Glu‐Val‐Asp‐aldehyde (DEVD‐CHO), or overexpression of either mitogen‐activated protein kinase kinase (MKK) 7 or Bcl‐xL canceled FADD‐mediated sensitization to etoposide‐induced apoptosis. Moreover, treatment with the caspase 8 inhibitor, benzyloxy‐carbonyl‐Val‐Ala‐Asp‐fluoromethylketone (z‐IETD‐fmk), or overexpression of viral FLICE/caspase‐8‐inhibitory protein (FLIP) from equine herpesvirus type 2 E8 also had an inhibitory effect, supporting a major involvement of a caspase 8‐dependent mitochondrial pathway. Interestingly, FADD was phosphorylated, and etoposide‐induced JNK/caspase activation and apoptosis were enhanced in the cells arrested at G2/M transition, but not in those overexpressing mutant FADD, in which 194 serine was replaced by alanine. Our results demonstrate that phosphorylated FADD‐dependent activation of the JNK/caspase pathway plays a pivotal role in sensitization to etoposide‐induced apoptosis in prostate cancer cells. Blackwell Publishing Ltd 2002-10 /pmc/articles/PMC5926882/ /pubmed/12417047 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01219.x Text en |
spellingShingle | Article Shimada, Keiji Nakamura, Mitsutoshi Ishida, Eiwa Kishi, Munehiro Yonehara, Shin Konishi, Noboru Phosphorylation of Fas‐associated Death Domain Contributes to Enhancement of Etoposide‐induced Apoptosis in Prostate Cancer Cells |
title | Phosphorylation of Fas‐associated Death Domain Contributes to Enhancement of Etoposide‐induced Apoptosis in Prostate Cancer Cells |
title_full | Phosphorylation of Fas‐associated Death Domain Contributes to Enhancement of Etoposide‐induced Apoptosis in Prostate Cancer Cells |
title_fullStr | Phosphorylation of Fas‐associated Death Domain Contributes to Enhancement of Etoposide‐induced Apoptosis in Prostate Cancer Cells |
title_full_unstemmed | Phosphorylation of Fas‐associated Death Domain Contributes to Enhancement of Etoposide‐induced Apoptosis in Prostate Cancer Cells |
title_short | Phosphorylation of Fas‐associated Death Domain Contributes to Enhancement of Etoposide‐induced Apoptosis in Prostate Cancer Cells |
title_sort | phosphorylation of fas‐associated death domain contributes to enhancement of etoposide‐induced apoptosis in prostate cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926882/ https://www.ncbi.nlm.nih.gov/pubmed/12417047 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01219.x |
work_keys_str_mv | AT shimadakeiji phosphorylationoffasassociateddeathdomaincontributestoenhancementofetoposideinducedapoptosisinprostatecancercells AT nakamuramitsutoshi phosphorylationoffasassociateddeathdomaincontributestoenhancementofetoposideinducedapoptosisinprostatecancercells AT ishidaeiwa phosphorylationoffasassociateddeathdomaincontributestoenhancementofetoposideinducedapoptosisinprostatecancercells AT kishimunehiro phosphorylationoffasassociateddeathdomaincontributestoenhancementofetoposideinducedapoptosisinprostatecancercells AT yoneharashin phosphorylationoffasassociateddeathdomaincontributestoenhancementofetoposideinducedapoptosisinprostatecancercells AT konishinoboru phosphorylationoffasassociateddeathdomaincontributestoenhancementofetoposideinducedapoptosisinprostatecancercells |